S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Xeris Biopharma (XERS) News Today

$1.74
-0.02 (-1.14%)
(As of 04/19/2024 ET)
SourceHeadline
finance.yahoo.com logoXeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
finance.yahoo.com - April 5 at 12:23 PM
finance.yahoo.com logoXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - April 3 at 6:23 PM
finance.yahoo.com logoXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 2 at 8:50 AM
marketbeat.com logoXeris Biopharma (NASDAQ:XERS) Now Covered by Oppenheimer
marketbeat.com - March 28 at 8:29 AM
proactiveinvestors.com logoXeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for 2024 Growth
proactiveinvestors.com - March 18 at 9:49 PM
finance.yahoo.com logoHere's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
finance.yahoo.com - March 9 at 1:59 PM
seekingalpha.com logoXeris Biopharma (XERS) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 8 at 7:43 PM
marketbeat.com logoBrokers Offer Predictions for Xeris Biopharma Holdings, Inc.'s Q2 2024 Earnings (NASDAQ:XERS)
marketbeat.com - March 8 at 6:35 AM
finance.yahoo.com logoXeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
finance.yahoo.com - March 7 at 2:41 PM
insidermonkey.com logoXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
insidermonkey.com - March 7 at 1:01 PM
marketbeat.com logoHC Wainwright Boosts Xeris Biopharma (NASDAQ:XERS) Price Target to $6.00
marketbeat.com - March 7 at 8:20 AM
finance.yahoo.com logoQ4 2023 Xeris Biopharma Holdings Inc Earnings Call
finance.yahoo.com - March 7 at 12:19 AM
marketwatch.com logoXeris Biopharma Shares Drop After Weak 4Q Results
marketwatch.com - March 6 at 7:18 PM
msn.com logoXeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84M
msn.com - March 6 at 7:18 PM
investorplace.com logoXERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023
investorplace.com - March 6 at 2:00 PM
proactiveinvestors.com logoXeris Biopharma secures $200M in capital in debt refinancing deal; sees big 4Q revenue jump
proactiveinvestors.com - March 6 at 9:57 AM
marketbeat.com logoXeris Biopharma (NASDAQ:XERS) Issues Earnings Results, Misses Estimates By $0.01 EPS
marketbeat.com - March 6 at 7:49 AM
businesswire.com logoXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
businesswire.com - March 6 at 7:02 AM
businesswire.com logoXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
businesswire.com - March 6 at 7:00 AM
businesswire.com logoXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
businesswire.com - February 28 at 7:00 AM
theglobeandmail.com logo3 Breakout Stocks Under $5 to Buy for More Upside
theglobeandmail.com - February 23 at 7:13 PM
marketbeat.com logoXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Short Interest Down 9.7% in January
marketbeat.com - February 15 at 1:58 AM
marketbeat.com logoFY2023 Earnings Forecast for Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Issued By Leerink Partnrs
marketbeat.com - February 8 at 6:43 AM
marketbeat.com logoResearch Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc.'s Q1 2024 Earnings (NASDAQ:XERS)
marketbeat.com - February 7 at 8:05 AM
finance.yahoo.com logoXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
finance.yahoo.com - February 5 at 9:27 AM
realmoney.thestreet.com logoBig Game or Small, Here's How to Go About Stalking a Trade
realmoney.thestreet.com - February 3 at 6:45 PM
marketwatch.com logoXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease Treatment
marketwatch.com - January 10 at 11:14 AM
marketwatch.com logoXeris Biopharma Shares Climb 12% on Amgen License Agreement
marketwatch.com - January 10 at 11:14 AM
msn.com logoWhy Is Xeris Biopharma (XERS) Stock Up 12% Today?
msn.com - January 10 at 11:14 AM
marketbeat.com logoTraders Buy Large Volume of Call Options on Xeris Biopharma (NASDAQ:XERS)
marketbeat.com - January 10 at 10:35 AM
seekingalpha.com logoXeris Biopharma: Speculative Buy, Size Your Position Accordingly
seekingalpha.com - January 9 at 7:27 AM
marketwatch.com logoXeris Biopharma Holdings Shares Jump 14% on Raised 2023 Outlook
marketwatch.com - January 4 at 2:58 PM
msn.com logoXeris Biopharma sees FY revenue at higher end of guidance
msn.com - January 4 at 9:58 AM
finance.yahoo.com logoXeris Biopharma Updates Its Outlook for 2023
finance.yahoo.com - January 4 at 9:58 AM
seekingalpha.com logoXeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024
seekingalpha.com - January 1 at 5:43 AM
seekingalpha.com logoXeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024
seekingalpha.com - January 1 at 5:43 AM
finance.yahoo.com logoXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 27 at 7:47 AM
sg.finance.yahoo.com logoXeris Biopharma Holdings, Inc. (0A8E.L)
sg.finance.yahoo.com - December 27 at 12:35 AM
finance.yahoo.com logoMy Top Small-Cap Stock Pick for 2024 Is a Biotech With a Big Opportunity
finance.yahoo.com - December 20 at 5:47 PM
uk.finance.yahoo.com logoXeris Pharmaceuticals, Inc. (XERS)
uk.finance.yahoo.com - December 3 at 2:38 PM
finance.yahoo.com logoPresident & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stock
finance.yahoo.com - November 20 at 8:50 AM
finance.yahoo.com logoXeris Biopharma CEO unveils game-changing drug innovations and record financial success
finance.yahoo.com - November 17 at 2:18 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Avidity Biosciences (RNA), Xeris Pharmaceuticals (XERS)
markets.businessinsider.com - November 14 at 11:53 PM
finance.yahoo.com logoXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 5:27 PM
morningstar.com logoXeris Biopharma Holdings Inc
morningstar.com - November 10 at 12:26 PM
finance.yahoo.com logoQ3 2023 Xeris Biopharma Holdings Inc Earnings Call
finance.yahoo.com - November 10 at 2:25 AM
proactiveinvestors.com logoXeris expects to hit the high end of revenue guidance after strong 3Q results
proactiveinvestors.com - November 9 at 4:25 PM
finance.yahoo.com logoI've Prescribed Myself This Biotech Stock to Get Through the Market Mess
finance.yahoo.com - November 9 at 4:25 PM
finance.yahoo.com logoXeris Biopharma Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 9 at 9:41 AM
finance.yahoo.com logoXeris Biopharma Holdings Inc (XERS) Reports Substantial Revenue Growth in Q3 2023
finance.yahoo.com - November 9 at 9:41 AM
Get Xeris Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter.

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

XERS Media Mentions By Week

XERS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XERS
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

XERS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XERS Articles
This Week

0

1

XERS Articles
Average Week

Get Xeris Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:XERS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners